Plaschke, K., Bent, F., Rosenhagen, C., Wagner, S., Hofer, S., & Kopitz, J. (2012). The inhibitory in-vitro effect of high-dose levosimendan on platelet function may be mediated through its action as a phosphodiesterase inhibitor. Coronary artery disease, 23(3), . https://doi.org/10.1097/MCA.0b013e32835167cc
Chicago-Zitierstil (17. Ausg.)Plaschke, Konstanze, Franziska Bent, Claudia Rosenhagen, Sören Wagner, Stefan Hofer, und Jürgen Kopitz. "The Inhibitory In-vitro Effect of High-dose Levosimendan on Platelet Function May Be Mediated Through Its Action as a Phosphodiesterase Inhibitor." Coronary Artery Disease 23, no. 3 (2012). https://doi.org/10.1097/MCA.0b013e32835167cc.
MLA-Zitierstil (9. Ausg.)Plaschke, Konstanze, et al. "The Inhibitory In-vitro Effect of High-dose Levosimendan on Platelet Function May Be Mediated Through Its Action as a Phosphodiesterase Inhibitor." Coronary Artery Disease, vol. 23, no. 3, 2012, https://doi.org/10.1097/MCA.0b013e32835167cc.